ND

Narmadha Devi Thanaselvan Sanjay Kishore

Active Director Director DIN 11370532
DIN 11370532 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Narmadha Devi Thanaselvan Sanjay Kishore

Data last updated:

Narmadha Devi Thanaselvan Sanjay Kishore is a Director at Insulcare Engineering Private Limited (since 2025).

DIN 11370532
Primary Designation Director
First Appointment 06 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20252025Active

Board colleagues of Narmadha Devi Thanaselvan Sanjay Kishore

NameDINCompanyDesignation
Palaniyappan Thanaselvan10817920Insulcare Engineering Private LimitedDirector

Directorship timeline

Open interactive timeline →
Insulcare Engineering Private Limited
Premium access

Shareholding and investment profile for Narmadha Devi Thanaselvan Sanjay Kishore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narmadha Devi Thanaselvan Sanjay Kishore

Narmadha Devi Thanaselvan Sanjay Kishore currently holds 1 directorship: Insulcare Engineering Private Limited (Director, since 06 Nov 2025).

Narmadha Devi Thanaselvan Sanjay Kishore was first appointed on 06 Nov 2025 as Director at Insulcare Engineering Private Limited.

The current boards of Narmadha Devi Thanaselvan Sanjay Kishore's companies include Palaniyappan Thanaselvan (Insulcare Engineering Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available